INM · InMed Pharmaceuticals Inc. Common Shares
View on chartInsiders & Stakes
| ADAR1 Capital Management, LLC 10% Owner | ▲ Buy | Open Market | 945,924 Shares held | 10/8/2026 | View profile |
| Johnson Shane Aaron SVP, GM of BayMedica LLC | ▲ Buy | Open Market | 304,595 Shares held | 1/6/2022 | View profile |
| Vivo Opportunity, LLC 10% Owner | ▲ Buy | Open Market | 75,019 Shares held | 7/16/2026 | View profile |
| Eric A. Adams President & CEO | ▲ Buy | Open Market | 43,959 Shares held | 2/20/2024 | View profile |
| Andrew Hull Director | ▲ Buy | Open Market | 38,258 Shares held | 2/21/2024 | View profile |
| COLWILL BRUCE CFO | ▲ Buy | Open Market | 11,515 Shares held | 1/24/2022 | View profile |
| Alexandra Diane Janet Mancini | ▼ Sell | Open Market | 0 Shares held | 7/31/2024 | View profile |
Transaction History
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 2,256 | $3K | 10/8/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 3,046 | $4K | 10/7/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 5,601 | $7K | 10/6/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 18,182 | $24K | 10/5/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 8,307 | $11K | 10/2/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 16,431 | $22K | 10/1/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 8,340 | $11K | 9/16/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 54,256 | $70K | 9/15/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 28,505 | $37K | 9/14/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 19 | $29 | 7/16/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 2 | $3 | 7/16/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 1,389 | $2K | 7/15/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 1,000 | $2K | 7/15/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 13,761 | $21K | 7/15/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 4,882 | $8K | 7/14/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 493 | $764 | 7/14/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 1,460 | $2K | 7/2/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 147 | $228 | 7/2/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 3,946 | $6K | 7/1/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 398 | $617 | 7/1/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 545 | $839 | 6/30/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 55 | $85 | 6/30/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 29,518 | $45K | 6/8/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 2,982 | $5K | 6/8/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 49,966 | $78K | 6/5/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 5,045 | $8K | 6/5/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 6,125 | $10K | 6/4/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 618 | $970 | 6/4/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 7,069 | $11K | 6/3/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 714 | $1K | 6/3/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 20,753 | $32K | 6/2/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 2,095 | $3K | 6/2/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 14,838 | $23K | 6/1/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 1,498 | $2K | 6/1/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 16,164 | $25K | 5/29/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 1,632 | $3K | 5/29/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 30,882 | $52K | 5/21/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 3,118 | $5K | 5/21/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 51,056 | $80K | 5/20/2026 |
| Vivo Opportunity, LLC | ▲ Buy | Open Market | 5,154 | $8K | 5/20/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 68,551 | $110K | 5/19/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 200,000 | $312K | 5/19/2026 |
| ADAR1 Capital Management, LLC | ▲ Buy | Open Market | 200,000 | $300K | 5/19/2026 |
| Alexandra Diane Janet Mancini | ▼ Sell | Open Market | 240 | $42 | 7/31/2024 |
| Andrew Hull | ▲ Buy | Open Market | 37,500 | $15K | 2/21/2024 |
| Eric A. Adams | ▲ Buy | Open Market | 41,600 | $15K | 2/20/2024 |
| Eric A. Adams | ▲ Buy | Open Market | 14,160 | $13K | 4/14/2022 |
| Eric A. Adams | ▲ Buy | Open Market | 8,560 | $7K | 4/13/2022 |
| COLWILL BRUCE | ▲ Buy | Open Market | 5,000 | $5K | 1/24/2022 |
| Johnson Shane Aaron | ▲ Buy | Open Market | 8,500 | $11K | 1/6/2022 |
| Johnson Shane Aaron | ▲ Buy | Open Market | 8,093 | $11K | 12/30/2021 |
| Johnson Shane Aaron | ▲ Buy | Open Market | 5,000 | $7K | 11/15/2021 |
| Eric A. Adams | ▲ Buy | Open Market | 8,800 | $15K | 9/29/2021 |
| COLWILL BRUCE | ▲ Buy | Open Market | 5,000 | $9K | 9/28/2021 |
| Eric A. Adams | ▲ Buy | Open Market | 11,400 | $20K | 9/28/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
INM: No recent news reported
There were no new announcements or events involving InMed Pharmaceuticals in the past week. The only article listed concerns Liquidia, which does not affect INM directly. Therefore, no new information is available to influence the company's outlook at this time.
INM: No recent news reported. There were no new announcements or events involving InMed Pharmaceuticals in the past week. The only article listed concerns Liquidia, which does not affect INM directly. Therefore, no new information is available to influence the company's outlook at this time.